Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free View research | View latest news | Sign up for updates

Contact Theodora Fifis

From: Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis

Contact corresponding author